Benevolent AI (Benevolent AI) EV-to-Revenue : 3.14 (As of Jun. 24, 2024)

View and export this data going back to 2023. Start your Free Trial

What is Benevolent AI EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Benevolent AI's enterprise value is $29.11 Mil. Benevolent AI's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $9.26 Mil. Therefore, Benevolent AI's EV-to-Revenue for today is 3.14.

The historical rank and industry rank for Benevolent AI's EV-to-Revenue or its related term are showing as below:

BAIVF' s EV-to-Revenue Range Over the Past 10 Years
Min: -3.2 Med: 9.44 Max: 259.76
Current: 3.19

During the past 6 years, the highest EV-to-Revenue of Benevolent AI was 259.76. The lowest was -3.20. And the median was 9.44.

BAIVF's EV-to-Revenue is ranked better than
70.1% of 1030 companies
in the Biotechnology industry
Industry Median: 7.73 vs BAIVF: 3.19

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-24), Benevolent AI's stock price is $0.56. Benevolent AI's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.08. Therefore, Benevolent AI's PS Ratio for today is 7.09.

Benevolent AI EV-to-Revenue Historical Data

The historical data trend for Benevolent AI's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Benevolent AI EV-to-Revenue Chart

Benevolent AI Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

26.91

11.46

Benevolent AI Quarterly Data
	Dec18	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial				-	-	26.91	-	11.46

Competitive Comparison of Benevolent AI's EV-to-Revenue

For the Biotechnology subindustry, Benevolent AI's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Benevolent AI's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Benevolent AI's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Benevolent AI's EV-to-Revenue falls into.

Benevolent AI EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Benevolent AI's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	29.109	/	9.263
	=	3.14

Benevolent AI's current Enterprise Value is $29.11 Mil.
Benevolent AI's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $9.26 Mil.

Benevolent AI (GREY:BAIVF) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Benevolent AI's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	0.56	/	0.079
	=	7.09

Benevolent AI's share price for today is $0.56.
Benevolent AI's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.08.

Benevolent AI EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Benevolent AI's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Benevolent AI (Benevolent AI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Benevolent AI (GREY:BAIVF) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

BAI:Netherlands 2XA:Germany

Address

4-8 Maple Street, London, GBR, W1T 5HD

Website

https://www.benevolent.com

Benevolent AI is a clinical-stage AI-enabled drug discovery company. It delivers novel drug candidates with a higher probability of clinical success than those developed using traditional methods. The Benevolent Platform powers a growing in-house pipeline of over 20 drug programmes, spanning from target discovery to clinical studies, and it maintains commercial collaborations with pharmaceutical companies.